title: Recombinant erythropoietin: does it really effect sensitization?
authors.affiliation: Barnes Hospital HLA Laboratory, Department of Surgery, St Louis, Missouri 63110.
authors.forename: D L
authors.initials: DL
authors.lastname: Phelan
authors.forename: S
authors.initials: S
authors.lastname: Hibbett
authors.forename: L
authors.initials: L
authors.lastname: Wetter
authors.forename: D W
authors.initials: DW
authors.lastname: Hanto
authors.forename: T
authors.initials: T
authors.lastname: Mohanakumar
mesh_terms: D000918:Antibody Specificity; D001402:B-Lymphocytes / Q000276:immunology; D001803:Blood Transfusion; D003602:Cytotoxicity, Immunologic; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000276:immunology* / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin